fromMedCity News
3 days agoTakeda Vows Appeal of $885M Jury Verdict in 'Pay-for-Delay' Antitrust Case - MedCity News
Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week in a jury awarding nearly $885 million in damages to pharmacies and wholesalers who had alleged that one such settlement illegally kept generic competition from entering the market.
Intellectual property law







